Biomedical Catalyst Accelerator Provider Pool EoI: late stage

Innovate UK, part of UK Research and Innovation (UKRI), is seeking expressions of interest to establish an approved provider pool to support delivery of the Biomedical Catalyst Accelerator Programme. The aim of this competition is to identify experienced providers with a proven track record of designing and delivering end to end accelerator programmes for innovative UK registered micro, small and medium sized enterprises (SMEs) aligned to Biomedical Catalyst or wider health and life sciences accelerator themes. Providers may be called upon over a period of up to three years to support programme delivery. This is the late stage accelerator strand, which requires applicants to demonstrate experience of delivering programmes supporting late stage innovative human health SMEs, including scale-up, investment readiness, regulatory strategy, market access or commercial growth. Support must be tailored to the needs of SMEs working across a wide range of biomedical and healthcare R&D themes including advanced therapies, biosciences, therapeutics, diagnostics, medical technologies, digital health, and healthy ageing. There is no immediate funding in this expression of interest competition, but total eligible project costs for any future funding will be 100% funded. Future accelerators are expected to support 10-15 participants per programme with total costs up to £500,000.